Question explored with the scientific record
How much magnesium should we take to supplement
There is no single right dose. The honest answer is that the trials tested specific doses for specific problems, and most people taking magnesium for general health are guessing.
The strongest evidence here is for people with a defined problem, not for everyone. In overweight and obese middle-aged adults, 350 mg a day for 24 weeks did not improve blood vessel function, blood pressure, cholesterol, glucose, insulin, or inflammation [1]. But in a small trial of 50 people with stable coronary artery disease, 365 mg a day for 6 months raised a measure of artery dilation by 11.1 points [1]. Same mineral, opposite result, different bodies. In people with or at risk of diabetes, supplementation lowered fasting glucose and improved insulin resistance [3], and a pooled analysis of 26 trials found benefits across glucose and blood pressure markers [2].
| Population | Dose tested | What happened |
|---|---|---|
| Overweight/obese adults | 350 mg/day, 24 wk | No change in any marker [1] |
| Stable coronary disease | 365 mg/day, 6 mo | Artery dilation up 11.1 points [1] |
| Moderate COVID inpatients | 300 mg/day | Less oxygen needed, 9 vs 14 [7] |
| Diabetes or at risk | pooled trials | Lower fasting glucose, better insulin sensitivity [3] |
For blood pressure, a review reports benefit at 240 mg a day or more, and over 600 mg a day for untreated high blood pressure [4]. A separate review found about 368 mg a day lowered systolic pressure by roughly 2 points [5]. Those are small effects, and one trial in women with low mineral intake found magnesium did nothing for blood pressure at all [6].
What this search cannot tell you: the safe upper limit, how much is too much, or whether long-term use helps anyone without a diagnosed deficiency. Those answers are not in these records. Deficiency is common, roughly 10 to 30 percent by one review's estimate [4], and serum tests miss it because most magnesium sits inside cells [5].
My call: if you have diabetes, high blood pressure, or heart disease, 300 to 400 mg a day is the range the trials actually tested, and the benefit is modest. If you are healthy, the evidence for supplementing is weak. Confidence: moderate for the tested populations, low for everyone else.
Sources used 7
-
Effects of long-term magnesium supplementation on endothelial function and cardiometabolic risk markers: A randomized controlled trial in overweight/obese adults
Daily 350 mg magnesium for 24 weeks did not improve endothelial function or cardiometabolic risk markers in overweight/obese middle-aged and elderly adults.
DOI: 10.1038/s41598-017-00205-9 -
Association of magnesium consumption with type 2 diabetes and glucose metabolism: A systematic review and pooled study with trial sequential analysis
This study systematically reviews and pools evidence from observational cohorts and randomized trials to evaluate how dietary magnesium intake relates to type 2 diabetes risk and how magnesium supplementation affects glucose metabolism, using trial sequential analysis to assess …
DOI: 10.1002/dmrr.3243 -
Effect of magnesium supplementation on glucose metabolism in people with or at risk of diabetes: a systematic review and meta-analysis of double-blind randomized controlled trials
This systematic review and meta-analysis investigates the effects of magnesium supplementation on glucose metabolism in individuals with diabetes or at high risk of diabetes, finding that magnesium treatment significantly reduces fasting plasma glucose and improves insulin sensi…
DOI: 10.1038/ejcn.2016.154 -
Hypomagnesemia: exploring its multifaceted health impacts and associations with blood pressure regulation and metabolic syndrome
A comprehensive review detailing how hypomagnesemia affects blood pressure regulation, endothelial and vascular function, inflammation, and metabolic syndrome, and evaluating magnesium status and supplementation strategies across diverse human studies.
DOI: 10.1186/s13098-025-01772-y -
Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis
A comprehensive review arguing that subclinical magnesium deficiency is widespread and a principal driver of cardiovascular disease, calling for public health action and broader magnesium optimization through diet and supplementation.
DOI: 10.1136/openhrt-2017-000668 -
Effect on Blood Pressure of Potassium, Calcium, and Magnesium in Women With Low Habitual Intake
Potassium supplementation lowered 24-hour blood pressure in normotensive women with low usual mineral intakes, whereas calcium, magnesium, and a combination of all three minerals did not.
DOI: 10.1161/01.hyp.31.1.131 -
A randomized clinical trial investigating the impact of magnesium supplementation on clinical and biochemical measures in COVID-19 patients
In moderate COVID-19 inpatients, magnesium supplementation reduced oxygen therapy need and improved oxygen saturation, quality of life, and depression scores, with no significant effects on respiratory rate, fever, hs-CRP, or TNF-α.
DOI: 10.1186/s12985-024-02362-6